News & Articles hepatitis delta Maxwell Biotech Venture Fund's Portfolio Company Hepatera Announces Initiation of a Pilot Clinical Trial Of Myrcludex ... MOSCOW, April 2, 2014 /PRNewswire/ -- ? Hepatera Ltd. announces initiation of a clinical trial investigating Myrcludex B in chronically HBV infected patients who are also infected with hepatitis delta ... April 2, 2014 - PR Newswire via Yahoo! Finance